Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.

Seo Y, Lee S, Das R, Jeong SB, Park CS, Kim M, Yoon DK, Sultana A, Das K, Lee JE, Jeon YH, Thanh Huong PT, Nhiem NX, Woo J

Open source

DOI: 10.3389/fphar.2025.1557193
Published: 2025
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1557193,
  title = {Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.},
  author = {Seo Y and Lee S and Das R and Jeong SB and Park CS and Kim M and Yoon DK and Sultana A and Das K and Lee JE and Jeon YH and Thanh Huong PT and Nhiem NX and Woo J},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1557193},
  url = {https://doi.org/10.3389/fphar.2025.1557193}
}

RIS

TY  - JOUR
TI  - Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.
AU  - Seo Y
AU  - Lee S
AU  - Das R
AU  - Jeong SB
AU  - Park CS
AU  - Kim M
AU  - Yoon DK
AU  - Sultana A
AU  - Das K
AU  - Lee JE
AU  - Jeon YH
AU  - Thanh Huong PT
AU  - Nhiem NX
AU  - Woo J
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1557193
UR  - https://doi.org/10.3389/fphar.2025.1557193
ER  -

APA

Y, S., S, L., R, D., SB, J., CS, P., M, K., DK, Y., A, S., K, D., JE, L., YH, J., PT, T. H., NX, N., & J, W. (2025). Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1557193

Source records

pubmed · retrieved 2026-09-25T13:33:27.189Z